Choosing a Research Facility Disinfectant: What Two Peer-Reviewed Studies Show About ClO2, Sporicidal Activity, and Animal Aversion

Start here: why sporicidal efficacy is the first question to ask

Not all disinfection claims are created equal — and the reason comes down to the microbiological disinfectant hierarchy. Pathogens are not uniformly vulnerable to chemical disinfection. They exist on a spectrum of resistance, and bacterial spores sit at the very top of that hierarchy — the hardest target in the entire microbial world.

This hierarchy has a critical practical implication for protocol selection: sporicidal efficacy demonstrates activity against some of the toughest pathogens to eradicate. Spore-forming bacteria are not simply harder to kill — they represent a categorically different challenge that most disinfectants cannot meet at all. If the organisms on your exclusion list include spore-formers, your disinfectant's label needs to reflect demonstrated activity against that class specifically.

With that context established, here is what peer-reviewed research conducted at two leading institutions actually shows when you test disinfectants against the organisms that matter most in research facilities.

Disinfectant efficacy: what the chemistry actually has to do

Efficacy claims on disinfectant labels are not all equivalent. Kill claims against vegetative bacteria are relatively easy to achieve. Performance against bacterial spores, non-enveloped viruses, and persistent pathogens requires different chemistry — and the gap between products is wider than most label comparisons reveal.

A 2019 study from the UC San Diego Animal Care Program (Moody et al., JAALAS Vol. 58(5)) tested six disinfectants against bacterial contaminants isolated from actual facility contamination events — including spore-forming species from Paenibacillus and Bacillus genera. These were not theoretical test organisms. They were the organisms that had already defeated an existing sterilization protocol.

The study tested MB-10 Tablets alongside a range of other disinfectants — including other chlorine oxide formulations, a peracetic acid-based product, an accelerated hydrogen peroxide product, concentrated hydrogen peroxide, and bleach. Full product details are available in the published study. The setting — a gnotobiotic core facility, where contamination is irreversible and recovery is not possible — represents the most demanding disinfection standard in life sciences research. If a product holds up there, it holds up everywhere.

That last finding matters beyond gnotobiotic applications. Any facility with spore-forming organisms on its exclusion list — which includes most barrier facilities, BSL-2 environments, and programs working with rodent pinworm or common environmental contaminants — needs a disinfectant with demonstrated sporicidal activity. A product that lacks demonstrated sporicidal activity on its label does not meet that requirement, regardless of chemistry class.

Sporicidal activity and material compatibility: full product comparison

The Moody 2019 study's material compatibility findings are equally relevant to general facility operations. Acrylic surfaces exposed to hydrogen peroxide showed visible pitting and fissuring in controlled testing, confirmed over a three-month field trial. MB-10 Tablets caused no visible surface damage to acrylic over the same period.

Source: Moody et al., JAALAS Vol. 58(5), September 2019. UC San Diego Animal Care Program.  *Full product names of all competitors tested are available in the published study.

For facilities experiencing unexplained premature equipment degradation, the disinfectant compatibility question is worth revisiting. Corrosion from repeated chemical exposure accumulates over months and rarely gets attributed to the disinfectant at the time. The three-month field trial in this study provides a published reference baseline for those comparisons.

The variable most facilities are not accounting for: animal aversion to disinfectant residues

Disinfectant selection in animal research facilities tends to get treated as a procurement decision. In practice, it is a scientific one. The product you choose affects your data, your animals, your equipment, and the people applying it — often in ways that are not visible until the damage is done.

A 2016 study from UCLA's Division of Laboratory Animal Medicine (Campagna et al., JAALAS Vol. 55(2)) evaluated surface disinfectants across three criteria: antiviral efficacy, material compatibility, and animal response to disinfectant residues. The third criterion is not standard practice — and its findings are among the most practically significant in the paper.

The study tested three mouse strains — Swiss Webster, C57Bl/6, and BALB/c — for innate aversion to residues left on surfaces after standard disinfectant application. Both sodium hypochlorite and a popular hydrogen peroxide-based competitor caused significant aversion across all three strains (p < 0.001 vs. tap water controls). The finding for the hydrogen peroxide-based product is especially consequential for research programs.

For facilities using a hydrogen peroxide-based disinfectant similar to the one tested in spaces where animals are housed, handled, or tested, Cage surfaces, transfer equipment, and behavioral testing apparatus are all potential exposure points. If you are running behavioral assays — anxiety paradigms, cognitive tests, any protocol sensitive to environmental disruption — residues from your disinfectant may be introducing a confounding variable your experimental design does not account for.

The study also tested whether animals would habituate with a preexposure protocol. After three consecutive days of exposure to the competitor's residues, aversion was reduced but not eliminated. Facilities that have assumed acclimation would resolve this over time are working from an assumption the data does not support.

Animal aversion comparison: what the UCLA data shows

Source: Campagna et al., JAALAS Vol. 55(2), March 2016. UCLA Division of Laboratory Animal Medicine.  *Full product names of all competitors tested are available in the published study.

The Vimoba finding holds particular significance for multi-strain facilities or any program running protocols where behavioral baselines are critical to data validity. The chlorine dioxide chemistry did not produce the aversion response that both hypochlorite and the hydrogen peroxide-based competitor did — and it did so consistently across phenotypically distinct strains.

What procurement and operations teams need to evaluate

The science above is written for researchers. This section addresses facility managers, purchasing coordinators, and operations teams who need to evaluate disinfectants on additional grounds: consistency, logistics, regulatory standing, and total cost of ownership.

For facilities running documented sanitation validation or maintaining records for IACUC or external audit purposes, tablet-format consistency has real practical value. Concentration variability is one of the harder protocol deviations to catch after the fact. A product with federal and state registration also provides a documented compliance basis that is harder to challenge than one relying on manufacturer-supplied data alone.

A framework for evaluating your current protocol

Whether you are reassessing an existing program or selecting a disinfectant for the first time, a few questions move the evaluation faster than reviewing product catalogs. Start with your most demanding requirement and work toward the chemistry that meets it.

1. 1
   Identify the most resistant organism on your exclusion list

   Spore-forming bacteria and non-enveloped viruses require disinfectants with demonstrated activity against those specific classes. If your program includes spore-formers — common in barrier facilities and most BSL-2 environments — the Moody 2019 data is directly relevant. The finding is not about a chemistry class — it is about a specific formulation that was tested and found to have no sporicidal activity at any concentration. Verify sporicidal claims on the label and EPA registration of your current product, regardless of chemistry.

2. 2
   Audit the surfaces and materials in regular disinfectant contact

   Acrylic, stainless steel, polycarbonate caging, and vinyl film all respond differently to repeated chemical exposure. Equipment replacement cycles that seem routine may be accelerated by disinfectant incompatibility. The material compatibility data from Moody 2019 provides a published reference for those comparisons. The hydrogen peroxide-based competitor discussed throughout this article has also been shown to cause cracking and clouding in acrylic caging — additional data on that finding is available here.

3. 3
   Assess animal contact with disinfectant residues

   Cage surfaces, transfer apparatus, and behavioral testing equipment are all exposure points. If your program includes behavioral assays or colonies sensitive to environmental disruption, the UCLA aversion data is directly applicable. The core finding is that the aversive component of the tested product was imperceptible to human staff — no odor, no visible residue. This type of problem cannot be identified through routine observation, which is precisely why the published aversion data is the only reliable way to evaluate it.

4. 4
   Evaluate staff occupational exposure profile

   Facility staff apply disinfectants in enclosed spaces, repeatedly, and often with limited ventilation. Safety data sheet hazard ratings, pH values, and compatibility with institutional waste disposal requirements all factor into long-term protocol sustainability. A disinfectant that creates occupational hazard exposure adds indirect costs that rarely appear in a per-unit price comparison.